Resmed (RMD) Net Margin (2009 - 2026)

Resmed's Net Margin history runs 18 years deep, the most recent figure standing at 27.86% for Q1 2026.

• Quarterly Net Margin fell 40.0% year-over-year to 27.86% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 27.44% (up 129.0% YoY) and the FY2025 annual result came in at 27.22%, up 543.0% from the prior year.
• Net Margin was 27.86% for Q1 2026 at Resmed, up from 27.59% in the prior quarter.
• Across five years, Net Margin topped out at 28.26% in Q1 2025 and bottomed at 17.96% in Q4 2023.
• A 5-year average of 23.79% and a median of 23.89% in 2024 frame the typical range for Net Margin.
• Annual changes were most pronounced in 2022 — Net Margin jumped 3092 bps — and 2023, when it slumped 380 bps.
• Resmed's Net Margin stood at 21.76% in 2022, then fell by 17 bps to 17.96% in 2023, then surged by 50 bps to 26.88% in 2024, then rose by 3 bps to 27.59% in 2025, then increased by 1 bps to 27.86% in 2026.
• Business Quant data shows RMD's Net Margin at 27.86% in Q1 2026, 27.59% in Q4 2025, and 26.1% in Q3 2025.